Stocktwits on MSN

Lyra Therapeutics To Conduct One More Trial For Chronic Rhinosinusitis Treatment Candidate

Shares of Lyra Therapeutics, Inc. (LYRA) rose 19% on Monday after the company stated that it intends to proceed with an ...